J2356 Injection tezepelumab-ekko, 1mg
Also known as: tezepelumab, Tezspire, TSLP antibody
Injection of tezepelumab-ekko, 1 milligram. A thymic stromal lymphopoietin antibody for asthma.
In Plain Language
asthma control medication; inflammatory pathway blocker
Clinical Context
Used for moderate-to-severe asthma as an add-on controller therapy. Tezepelumab targets TSLP upstream in asthma inflammation pathway.
RVU Information
CPT J2356 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J2356?
CPT J2356 (Injection tezepelumab-ekko, 1mg) is a J Codes (Drugs) code. Injection of tezepelumab-ekko, 1 milligram. A thymic stromal lymphopoietin antibody for asthma.
How is J2356 administered?
CPT J2356 is administered by a healthcare provider, typically via injection or infusion. Used for moderate-to-severe asthma as an add-on controller therapy. Tezepelumab targets TSLP upstream in asthma inflammation pathway. It is used by Pulmonology, Allergy/Immunology.
When is CPT J2356 used?
Used for moderate-to-severe asthma as an add-on controller therapy. Tezepelumab targets TSLP upstream in asthma inflammation pathway.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.